PT3868758T - Derivados de tiadiazole e sua utilização como inibidores gls1 de para o tratamento de cancro - Google Patents
Derivados de tiadiazole e sua utilização como inibidores gls1 de para o tratamento de cancroInfo
- Publication number
- PT3868758T PT3868758T PT198742686T PT19874268T PT3868758T PT 3868758 T PT3868758 T PT 3868758T PT 198742686 T PT198742686 T PT 198742686T PT 19874268 T PT19874268 T PT 19874268T PT 3868758 T PT3868758 T PT 3868758T
- Authority
- PT
- Portugal
- Prior art keywords
- thiadiazole derivative
- gls1 inhibitor
- gls1
- inhibitor
- thiadiazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811202713 | 2018-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3868758T true PT3868758T (pt) | 2023-02-16 |
Family
ID=70284303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT198742686T PT3868758T (pt) | 2018-10-16 | 2019-10-15 | Derivados de tiadiazole e sua utilização como inibidores gls1 de para o tratamento de cancro |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11230544B1 (pt) |
| EP (1) | EP3868758B1 (pt) |
| JP (1) | JP7026852B2 (pt) |
| KR (1) | KR102379226B1 (pt) |
| CN (1) | CN112888686B (pt) |
| AU (1) | AU2019363115B2 (pt) |
| CA (1) | CA3116440C (pt) |
| ES (1) | ES2939506T3 (pt) |
| PT (1) | PT3868758T (pt) |
| WO (1) | WO2020078350A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115594683B (zh) * | 2021-11-02 | 2023-06-16 | 杭州禹胜医药科技有限公司 | 谷氨酰胺酶gls1抑制剂及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8604016B2 (en) * | 2011-11-21 | 2013-12-10 | Calithera Biosciences Inc. | Heterocyclic inhibitors of glutaminase |
| EA026656B1 (ru) * | 2011-11-21 | 2017-05-31 | Калитера Байосайенсиз Инк. | Гетероциклические ингибиторы глютаминазы |
| GB201409624D0 (en) | 2014-05-30 | 2014-07-16 | Astrazeneca Ab | 1,3,4-thiadiazole compounds and their use in treating cancer |
| ES2794868T3 (es) | 2015-06-30 | 2020-11-19 | Univ Texas | Inhibidores de GLS1 para el tratamiento de enfermedades |
| US10323028B2 (en) * | 2015-11-30 | 2019-06-18 | Astrazeneca Ab | 1,3,4-thiadiazole compounds and their use in treating cancer |
| US9938265B2 (en) * | 2015-11-30 | 2018-04-10 | Astrazeneca Ab | 1,3,4-thiadiazole compounds and their use in treating cancer |
| US10040789B2 (en) * | 2015-11-30 | 2018-08-07 | Astrazeneca Ab | 1,3,4-thiadiazole compounds and their use in treating cancer |
| CN109503570B (zh) * | 2015-12-18 | 2020-08-25 | 诺言医药科技(上海)有限公司 | 一种含有索拉非尼的药物组合物及其应用 |
-
2019
- 2019-10-15 JP JP2021521183A patent/JP7026852B2/ja active Active
- 2019-10-15 CN CN201980066987.8A patent/CN112888686B/zh active Active
- 2019-10-15 AU AU2019363115A patent/AU2019363115B2/en active Active
- 2019-10-15 ES ES19874268T patent/ES2939506T3/es active Active
- 2019-10-15 KR KR1020217014579A patent/KR102379226B1/ko active IP Right Grant
- 2019-10-15 US US17/284,806 patent/US11230544B1/en active Active
- 2019-10-15 PT PT198742686T patent/PT3868758T/pt unknown
- 2019-10-15 WO PCT/CN2019/111232 patent/WO2020078350A1/zh unknown
- 2019-10-15 CA CA3116440A patent/CA3116440C/en active Active
- 2019-10-15 EP EP19874268.6A patent/EP3868758B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3868758B1 (en) | 2023-01-04 |
| KR102379226B1 (ko) | 2022-03-25 |
| WO2020078350A1 (zh) | 2020-04-23 |
| KR20210066010A (ko) | 2021-06-04 |
| CA3116440C (en) | 2022-03-08 |
| EP3868758A4 (en) | 2021-11-03 |
| JP7026852B2 (ja) | 2022-02-28 |
| US11230544B1 (en) | 2022-01-25 |
| CN112888686B (zh) | 2022-04-19 |
| CA3116440A1 (en) | 2020-04-23 |
| ES2939506T3 (es) | 2023-04-24 |
| JP2021531331A (ja) | 2021-11-18 |
| CN112888686A (zh) | 2021-06-01 |
| EP3868758A1 (en) | 2021-08-25 |
| AU2019363115A1 (en) | 2021-05-27 |
| AU2019363115B2 (en) | 2021-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278171A (en) | Glucose-dependent insulin polypeptide and its uses | |
| EP3626699A4 (en) | SSAO INHIBITOR | |
| IL268981A (en) | Solid forms and combined preparations containing beta-lactamase inhibitor and uses thereof | |
| IL269711A (en) | ASK1 inhibitory compounds and their uses | |
| IL283330A (en) | Combined preparations containing a beta-lactamase inhibitor and their uses | |
| GB201705971D0 (en) | Inhibitor compounds | |
| IL269803A (en) | Implications of 6-pyrimidine-isoindole as an ERK1/2 inhibitor | |
| EP3572400A4 (en) | EZH2 INHIBITOR AND USE OF IT | |
| ZA201808618B (en) | Benzotriazole-derived a and b unsaturated amide compound used as tgf-br1 inhibitor | |
| EP3336091A4 (en) | IRAQ4 INHIBITOR AND ITS USE | |
| IL277778B (en) | inhibitors of bcl6 | |
| EP3543240A4 (en) | URAT1 INHIBITOR AND USE THEREOF | |
| EP3336090A4 (en) | INHIBITOR OF IRAQ4 AND ITS USE | |
| EP3674352A4 (en) | LIGNINE DERIVATIVE ASSOCIATION AND USE THEREOF | |
| EP3720436A4 (en) | TUBULIN INHIBITORS | |
| GB201819126D0 (en) | Inhibitor compounds | |
| EP3415524A4 (en) | INHIBITOR OF EXPRESSION OF α-SYNUCLEIN | |
| EP3600301A4 (en) | KDM4 INHIBITORS | |
| EP3661505A4 (en) | BENZOTHIAZOLE AND RELATED COMPOUNDS | |
| IL277806A (en) | Growth inhibitor | |
| PT3868758T (pt) | Derivados de tiadiazole e sua utilização como inibidores gls1 de para o tratamento de cancro | |
| EP3704104A4 (en) | IRAK4 INHIBITORS AND THEIR USES | |
| EP3684354A4 (en) | XPA INHIBITOR CONNECTIONS AND THEIR USE | |
| EP3640250A4 (en) | COMPOUND USED AS A GLS1 INHIBITOR | |
| EP3571330A4 (en) | SYNERGISTIC CORROSION INHIBITORS |